BINP
Price:
$0.02
Market Cap:
$1.08M
Bionoid Pharma, Inc. operates as a medical device company. It develops and markets innovative medical devices and technologies for the orthopedic and pain management markets. The company was founded on October 20, 1997 and is headquartered in Beverly Hills, CA.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-06-29
Stock Exchange
OTC
Ticker
BINP
According to Bionoid Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -27.93%. This represents a change of 1.07% compared to the average of -2.38% of the last 4 quarters.
The mean historical ROE of Bionoid Pharma, Inc. over the last ten years is 265.25%. The current -27.93% ROE has changed -110.53% with respect to the historical average. Over the past ten years (40 quarters), BINP's ROE was at its highest in in the March 2011 quarter at 383.65%. The ROE was at its lowest in in the June 2021 quarter at -3068.46%.
Average
265.25%
Median
157.82%
Minimum
-13.95%
Maximum
1.11%
Discovering the peaks and valleys of Bionoid Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 16.93%
Maximum Annual ROE = 1.11%
Minimum Annual Increase = -101.12%
Minimum Annual ROE = -13.95%
| Year | ROE | Change |
|---|---|---|
| 2024 | 0% | -100.00% |
| 2023 | -13.95% | 619.62% |
| 2022 | -1.94% | -101.12% |
| 2021 | 173.73% | -84.41% |
| 2020 | 1.11% | 16.93% |
| 2019 | 6.54% | -95.39% |
| 2013 | 141.92% | -73.84% |
| 2011 | 542.58% | 20.88% |
| 2010 | 448.85% | 86.67% |
| 2009 | 240.45% | 130.27% |
The current ROE of Bionoid Pharma, Inc. (BINP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-5.30%
5-year avg
254.43%
10-year avg
265.25%
Bionoid Pharma, Inc.’s ROE is less than Body and Mind Inc. (6.53%), less than Sproutly Canada Inc. (1.87%), greater than Medical Marijuana, Inc. (-0.84%), less than Anything Technologies Media, Inc. (23.64%), less than BioTech Medics, Inc. (0.01%), less than Endexx Corporation (56.85%), greater than CTT Pharmaceutical Holdings, Inc. (-195.45%), less than Herborium Group, Inc. (7.97%), less than Target Group Inc. (12.93%), greater than Yooma Wellness Inc. (-246.27%),
| Company | ROE | Market cap |
|---|---|---|
| 6.53% | $14.63K | |
| 1.87% | $3.13K | |
| -0.84% | $1.14M | |
| 23.64% | $1.64M | |
| 0.01% | $1.68M | |
| 56.85% | $875.55K | |
| -195.45% | $1.39M | |
| 7.97% | $1.09M | |
| 12.93% | $1.11M | |
| -246.27% | $381.10K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionoid Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionoid Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bionoid Pharma, Inc.'s ROE?
How is the ROE calculated for Bionoid Pharma, Inc. (BINP)?
What is the highest ROE for Bionoid Pharma, Inc. (BINP)?
What is the 3-year average ROE for Bionoid Pharma, Inc. (BINP)?
What is the 5-year average ROE for Bionoid Pharma, Inc. (BINP)?
How does the current ROE for Bionoid Pharma, Inc. (BINP) compare to its historical average?